Neutralization of Epstein-Barr Virus by Nonimmune Human Serum

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

1964 • 2,643 citations

Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines

1973 • 1,718 citations

Third component of human complement: purification from plasma and physicochemical characterization

1976 • 523 citations

Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.

1975 • 368 citations

A procedure for removing red cells and dead cells from lymphoid cell suspensions

1975 • 303 citations

Purification and radiolabeling of human C1q.

1981 • 295 citations

Malignant Lymphoma in Cottontop Marmosets after Inoculation with Epstein-Barr Virus

1973 • 290 citations

Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.

1977 • 210 citations

Infectious Mononucleosis

1976 • 197 citations

FOURTH COMPONENT OF HUMAN COMPLEMENT: DESCRIPTION OF A THREE POLYPEPTIDE CHAIN STRUCTURE

1974 • 192 citations

Observations on Childhood Infections with the Epstein-Barr Virus

1970 • 180 citations

Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.

1978 • 172 citations

Type-Common CP-1 Antigen of Herpes Simplex Virus Is Associated with a 59,000-Molecular-Weight Envelope Glycoprotein

1978 • 141 citations

The Morphological and Biological Effects of Various Antisera on Avian Infectious Bronchitis Virus

1968 • 134 citations

DNA of Epstein-Barr virus. I. Comparative studies of the DNA of Epstein-Barr virus from HR-1 and B95-8 cells: size, structure, and relatedness

1975 • 119 citations

Anatomy of Herpes Simplex Virus DNA. VIII. Properties of the Replicating DNA

1977 • 118 citations

Isolation and Characterization of the Proenzyme Form of the C1s Subunit of the First Complement Component

1974 • 118 citations

Neutralization of Sensitized Virus by Purified Components of Complement

1970 • 118 citations

The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon.

1981 • 117 citations

Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood

1975 • 98 citations

Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced fc-binding receptors

1982 • 97 citations

Development and Persistence of Immunity to Epstein-Barr Virus in Man

1970 • 97 citations

Physicochemical and Functional Characterization of the C1r Subunit of the First Complement Component

1976 • 93 citations

Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.

1981 • 90 citations

COMPLEMENT COMPONENTS REQUIRED FOR VIRUS NEUTRALIZATION BY EARLY IMMUNOGLOBULIN ANTIBODY

1969 • 90 citations

Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein‐Barr virus transformation of the cells

1978 • 88 citations

Neutralization of Sensitized Virus by the Fourth Component of Complement

1969 • 81 citations

Epstein-Barr-Virus Immunity and Tissue Distribution in a Fatal Case of Infectious Mononucleosis

1978 • 80 citations

A simplified procedure for the purification of C1̄‐inactivator from human plasma Interaction with complement subcomponents C1̄r and C1̄s

1977 • 78 citations

The Development by Cytomegalovirus-Infected Cells of Binding Affinity for Normal Human Immunoglobulin

1976 • 72 citations

Immunodeficiency to the Epstein-Barr virus in the X-linked recessive lymphoproliferative syndrome

1978 • 63 citations

Infectious Mononucleosis: Appearance of Neutralizing Antibody to Epstein-Barr Virus Measured by Inhibition of Formation of Lymphoblastoid Cell Lines

1972 • 63 citations

FORMATION AND BIOLOGIC ROLE OF POLYOMA VIRUS-ANTIBODY COMPLEXES

1974 • 63 citations

The second component of human complement (C2): Quantitative molecular analysis of its reactions in immune hemolysis

1970 • 62 citations

Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement

1980 • 60 citations

Neutralizing Antibodies to Epstein-Barr Virus in Healthy Populations and Patients with Infectious Mononucleosis

1973 • 59 citations

Isolation of Epstein Barr-virus and studies of its neutralization by human IgG and complement.

1981 • 52 citations

Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.

1977 • 50 citations

T lymphocyte-mediated cytotoxicity against autologous EBV-genome-bearing B cells.

1981 • 47 citations

Complement-Requiring Neutralizing Antibodies in Hyperimmune Sera to Human Cytomegaloviruses

1971 • 41 citations

Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells

1979 • 41 citations

Inhibition of the in Vitro Outgrowth of Epstein-Barr Virus-Infected Lymphocytes by TG Lymphocytes

1979 • 38 citations

Effect of Selective Complement Deficiency on the Rate of Neutralization of Enveloped Viruses by Human Sera

1977 • 34 citations

The Mechanisms of Neutralization of Sensitized Equine Arteritis Virus by Complement Components

1974 • 27 citations

Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus.

1981 • 27 citations

Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements.

1978 • 24 citations

Antibody-Independent Neutralization of Vesicular Stomatitis Virus by Human Complement

1979 • 21 citations

Rate-zonal centrifugation of herpes simplex virus-antibody complexes

1971 • 18 citations

C5̄6̄7̄-Initiated Cytolysis of Lymphoid Cells: Description of the Phenomenon and Studies on Its Control by C5̄6̄7̄ Inhibitors

1977 • 17 citations

Complement requirement for virus neutralization by antibody and reduced serum complement levels associated with experimental equine herpesvirus 1 infection

1981 • 13 citations

Serum IgA Antibodies to Epstein-Barr Virus (EBV)-Related Antigens a New Feature of Nasopharyngeal Carcinoma1

2015 • 12 citations

Production of rabbit antibodies against the viral capsid antigen (VCA) of the epstein‐barr virus (EBV)

1978 • 4 citations